1.
Axelrod J, Wurtman RJ: Photic and neural control of indoleamine metabolism in the rat pineal gland. Advances in pharmacology 1968, 6(Pt A):157-166.
2.
Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali
DP: Physiological effects of melatonin: role of melatonin receptors and signal transduction
pathways. Progress in neurobiology 2008, 85(3):335-353.
3.
Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR: Melatonin--a pleiotropic, orchestrating regulator molecule. Progress in neurobiology 2011, 93(3):350-384.
4.
Ekmekcioglu C, Thalhammer T, Humpeler S, Mehrabi MR, Glogar HD, Holzenbein T, Markovic
O, Leibetseder VJ, Strauss-Blasche G, Marktl W: The melatonin receptor subtype MT2 is present in the human cardiovascular system. Journal of pineal research 2003, 35(1):40-44.
5.
Dominguez-Rodriguez A: Melatonin in cardiovascular disease. Expert Opin Investig Drugs 2012, 21(11):1593-1596.
6.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ, Sanchez J, Marrero F, de Armas-Trujillo
D: Decreased nocturnal melatonin levels during acute myocardial infarction. Journal of pineal research 2002, 33(4):248-252.
7.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter RJ: Decreased level of melatonin in serum predicts left ventricular remodelling after
acute myocardial infarction. Journal of pineal research 2012, 53(3):319-323.
8.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Reiter RJ: Prognostic value of nocturnal melatonin levels as a novel marker in patients with
ST-segment elevation myocardial infarction. The American journal of cardiology 2006, 97(8):1162-1164.
9.
McMullan CJ, Rimm EB, Schernhammer ES, Forman JP: A nested case-control study of the association between melatonin secretion and incident
myocardial infarction. Heart 2017, 103(9):694-701.
10.
Di WL, Kadva A, Djahanbakhch O, Silman R: Radioimmunoassay of bound and free melatonin in plasma. Clinical chemistry 1998, 44(2):304-310.
11.
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis
SG, Guyton RA, Hollenberg SM et al: 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary:
a report of the American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and
Interventions. Circulation 2011, 124(23):2574-2609.
12.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange
RA, Mack MJ, Mauri L et al: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in
Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American
Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011
ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline
for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline
for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013
ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014
AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary
Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and
Management of Patients Undergoing Noncardiac Surgery. Circulation 2016, 134(10):e123-155.
13.
Li JW, Chen YD, Liu YQ, Wang JD, Chen WR, Zhang YQ, Ma Q: Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic
function in patients with ST-segment elevation myocardial infarction. Scientific reports 2017, 7(1):6097.
14.
Li JW, Chen YD, Chen WR, You Q, Li B, Zhou H, Zhang Y, Han TW: Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction. Cardiovasc Diabetol 2017, 16(1):72.
15.
Pei HF, Hou JN, Wei FP, Xue Q, Zhang F, Peng CF, Yang Y, Tian Y, Feng J, Du J et al: Melatonin attenuates postmyocardial infarction injury via increasing Tom70 expression. Journal of pineal research 2017, 62(1).
16.
Hu J, Zhang L, Yang Y, Guo Y, Fan Y, Zhang M, Man W, Gao E, Hu W, Reiter RJ et al: Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting
Mst1. Journal of pineal research 2017, 62(1).
17.
Sahna E, Acet A, Ozer MK, Olmez E: Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental
physiological or pharmacological doses of melatonin. Journal of pineal research 2002, 33(4):234-238.
18.
Halladin NL, Ekelof S, Jensen SE, Aaroe J, Kjaergaard B, Heegaard PM, Lykkesfeldt
J, Rosenberg J, Gogenur I: Melatonin does not affect oxidative/inflammatory biomarkers in a closed-chest porcine
model of acute myocardial infarction. In vivo (Athens, Greece) 2014, 28(4):483-488.
19.
Hausenloy DJ, Garcia-Dorado D, Erik Botker H, Davidson SM, Downey J, Engel FB, Jennings
R, Lecour S, Leor J, Madonna R et al: Melatonin as a cardioprotective therapy following ST-segment elevation myocardial
infarction: is it really promising? Reply. Cardiovascular research 2017, 113(11):1418-1419.
20.
Dominguez-Rodriguez A, Abreu-Gonzalez P, de la Torre-Hernandez JM, Gonzalez-Gonzalez
J, Garcia-Camarero T, Consuegra-Sanchez L, Garcia-Saiz MD, Aldea-Perona A, Virgos-Aller
T, Azpeitia A et al: Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous
coronary intervention for acute ST-elevation myocardial infarction: Results of the
Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial. Journal of pineal research 2017, 62(1).
21.
Ekelof SV, Halladin NL, Jensen SE, Zaremba T, Aaroe J, Kjaergaard B, Simonsen CW,
Rosenberg J, Gogenur I: Effects of intracoronary melatonin on ischemia-reperfusion injury in ST-elevation
myocardial infarction. Heart Vessels 2016, 31(1):88-95.
22.
Dominguez-Rodriguez A, Abreu-Gonzalez P, de la Torre-Hernandez JM, Consuegra-Sanchez
L, Piccolo R, Gonzalez-Gonzalez J, Garcia-Camarero T, Del Mar Garcia-Saiz M, Aldea-Perona
A, Reiter RJ et al: Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With
ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
(From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty
Trial). The American journal of cardiology 2017, 120(4):522-526.
23.
Ghaeli P, Vejdani S, Ariamanesh A, Hajhossein Talasaz A: Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention:
a Randomized Controlled Trial. Iranian journal of pharmaceutical research : IJPR 2015, 14(3):851-855.
24.
Bagci S, Altuntas O, Katzer D, Berg C, Willruth A, Reutter H, Bartmann P, Muller A,
Zur B: Evaluation of two commercially available ELISA kits for the determination of melatonin
concentrations in amniotic fluid throughout pregnancy. Annals of clinical biochemistry 2017, 54(1):107-112.